Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals

BACKGROUND AND AIMS: Chronic hepatitis C is a systemic disease and type 2 diabetes mellitus (T2DM) belongs to more common extrahepatic. The aim of this study was to (i) explore the prevalence of impaired fasting glucose (IFG) and T2DM in patients with chronic hepatitis C, (ii) explore the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Drazilova, Sylvia, Janicko, Martin, Skladany, Lubomir, Kristian, Pavol, Oltman, Marian, Szantova, Maria, Krkoska, Dusan, Mazuchova, Eva, Piesecka, Lubica, Vahalova, Veronika, Rac, Marek, Schreter, Ivan, Virag, Ladislav, Koller, Tomas, Liptakova, Adriana, Ondrasova, Miriam, Jarcuska, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192081/
https://www.ncbi.nlm.nih.gov/pubmed/30402450
http://dx.doi.org/10.1155/2018/6095097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192081/
https://www.ncbi.nlm.nih.gov/pubmed/30402450
http://dx.doi.org/10.1155/2018/6095097

Ejemplares similares